| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |